# Afatinib Genomic Landscape

> **NCT02491775** · — · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 6 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Non-Small Cell Lung Cancer
- Non-small Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02491775
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06-11
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-02-28
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Changes in treatment plan affecting drug therapy choices
- **Last updated:** 2018-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491775, "Afatinib Genomic Landscape". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02491775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*